Other OTC Pharmaceuticals (Pharmacies) - Southern Asia

  • Southern Asia
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$187.80m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.49%, resulting in a market volume of US$212.40m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.10 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Southern Asia is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors are all contributing to this positive trajectory. Customer preferences in Southern Asia are playing a crucial role in the growth of the Other OTC Pharmaceuticals (Pharmacies) market. As the region becomes more urbanized and affluent, there is an increasing demand for convenient and accessible healthcare products. Consumers are seeking over-the-counter medications that can be easily purchased without a prescription, allowing them to self-diagnose and self-medicate for common ailments. This preference for convenience and autonomy is driving the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Southern Asia. Trends in the market are also contributing to its development. With the rise of e-commerce and digital platforms, online pharmacies are gaining popularity in Southern Asia. Consumers are now able to purchase over-the-counter medications from the comfort of their homes, with the added convenience of home delivery. This trend is particularly evident in urban areas, where busy lifestyles and traffic congestion make online shopping a more attractive option. The online presence of pharmacies is expanding rapidly, with a wide range of products and competitive pricing, further driving the growth of the Other OTC Pharmaceuticals (Pharmacies) market. Local special circumstances in Southern Asia are also shaping the development of the market. The region is characterized by a large population and a growing middle class. This demographic shift is leading to increased healthcare spending and a greater demand for over-the-counter medications. Additionally, Southern Asia is home to a number of traditional medicine practices, such as Ayurveda and traditional Chinese medicine. These practices often rely on herbal remedies and natural ingredients, which align with the growing global trend towards natural and alternative healthcare. The presence of these traditional medicine practices is influencing the product offerings in the Other OTC Pharmaceuticals (Pharmacies) market, with a focus on natural and herbal remedies. Underlying macroeconomic factors are further supporting the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Southern Asia. Economic growth, rising disposable incomes, and increasing healthcare expenditure are all contributing to the expansion of the market. As Southern Asian countries continue to develop and improve their healthcare infrastructure, access to over-the-counter medications is becoming more widespread. This favorable economic environment is attracting both domestic and international players to invest in the market, further driving its growth. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Southern Asia is experiencing significant growth and development. Customer preferences for convenience and autonomy, along with the rise of online pharmacies, are driving this growth. Local special circumstances, such as the growing middle class and the presence of traditional medicine practices, are shaping the market. Underlying macroeconomic factors, including economic growth and rising healthcare expenditure, are further supporting the expansion of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)